🔗 Permalink

Assignee profile:

PCI Biotech AS

City:

Oslo

Country:

Norway

Published Applications:

Last publication date:

2026-04-16

Patent Grants:

Last grant date:

2025-04-01

Top Inventors for applications by PCI Biotech AS

These are the the leading inventors for applications assigned to PCI Biotech AS:

Anders Hogset 9 Oslo, Norway
Anders HØGSET 8 Oslo, Norway
Pål JOHANSEN 3 Winterthur, Switzerland
Per Edvard WALDAY 2 Oslo, Norway

Pål Kristian SELBO 2 Oslo, Norway
Sigurd Bøe 2 Oslo, Norway
Kristin EIVINDVIK 2 Fornebu, Norway
Eivind Johannes Hovig 2 Oslo, Norway

Kristian Berg 2 Heggedal, Norway
P{dot over (a)}l Kristian Selbo 1 Oslo, Norway
Morten LUHR 1 Oslo, Norway
Sigurd Boe 1 Horten, Norway

Xiaolin ZHANG 1 Amsterdam, Netherlands
Oystein Fodstad 1 Oslo, Norway
Lena FINNESAND 1 Oslo, Norway
Vivek S. Gaware 1 Reykjavik, Iceland

Sebastian A.J. ZAAT 1 Amsterdam, Netherlands
Mar Masson 1 Reykjavik, Iceland
Anette WEYERGANG 1 Oslo, Norway
Sebastian A. J. Zaat 1 Amsterdam, Netherlands

Karin NORD 1 Vøyenenga, Norway
Eivind Hovig 1 Oslo, Norway

Recent patent applications by PCI Biotech AS

PCI Biotech AS based in Oslo, NO has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-04-16

US20260103730A1

Chemistry; metallurgy

METHOD FOR RELEASING VIRAL VECTORS

#2 | 2024-04-11

US20240115731A1

Human necessities

METHOD OF DELIVERING MRNA IN VIVO

#3 | 2021-02-25 ✅ Patent 12,263,182 granted on 2025-04-01

US20210052628A1

Human necessities

Method of introducing an mRNA molecule into a cell

#4 | 2020-10-29

US20200338044A1

Human necessities

TREATMENT OF CHOLANGIOCARCINOMA WITH TPCS-2A INDUCED PHOTOCHEMICAL INTERNALISATION OF GEMCITABINE

#5 | 2020-08-27 ✅ Patent 11,648,287 granted on 2023-05-16

US20200268834A1

Human necessities

Composition for the treatment of intracellular bacterial infection

#6 | 2018-02-22 ✅ Patent 11,027,017 granted on 2021-06-08

US20180050105A1

Human necessities

PCI method for generating immune respose to antigenic molecule using checkpoint inhibitor and TLR3 ligand

#7 | 2017-09-07 ✅ Patent 10,537,639 granted on 2020-01-21

US20170252441A1

Human necessities

Compound and method

#8 | 2017-05-25 ✅ Patent 10,973,896 granted on 2021-04-13

US20170143811A1

Human necessities

Treatment or prevention of melanoma using photochemical internalization of a melanoma antigen

#9 | 2016-07-21 ✅ Patent 10,610,582 granted on 2020-04-07

US20160206725A1

Human necessities

Compound and method for vaccination and immunisation

#10 | 2016-07-14 ✅ Patent 10,166,401 granted on 2019-01-01

US20160199664A1

Human necessities

Antigen delivery device and method

#11 | 2015-07-23 ✅ Patent 9,901,636 granted on 2018-02-27

US20150202293A1

Human necessities

Conjugate of a photosensitiser and chitosan and uses thereof

#12 | 2012-10-18 ✅ Patent 9,700,622 granted on 2017-07-11

US20120264807A1

Human necessities

Method for introducing siRNA into cells by photochemical internalisation

#13 | 2011-12-01 ✅ Patent 9,241,996 granted on 2016-01-26

US20110293575A1

Human necessities

Photochemical internalisation of kinase inhibitors

#14 | 2011-07-14

US20110171184A1

Chemistry; metallurgy

Method for Introducing a Pna Molecule Conjugated to a Positively Charged Peptide into the Cytosol and/or the Nucleus by Photochemical Internalisation (Pci)

#15 | 2009-12-03

US20090297487A1

Human necessities

METHOD FOR INTRODUCING SIRNA INTO CELLS BY PHOTOCHEMICAL INTERNALISATION

Also check out PCI Biotech AS's (Oslo, Norway) applicant profile with 7 patent applications submitted.

AssigneeID:

122423 ⎘